Carbamazepine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 60290-059
  • Package NDC 60290-059-01
  • Package NDC 60290-059-02
  • Application number ANDA216594
  • SPL ID 5e7d0501-07b8-8664-e063-6394a90a7e70
  • SPL set ID 48080efd-1781-4585-83f8-c43957ac63b3
  • UNII 33CM23913M
  • RxCUI 199378
  • RxCUI 402505
  • RxCUI 402506

What the source publishes

Labeler
Umedica Laboratories USA Inc.
Active ingredients
Carbamazepine
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:60290-059_5e7d0501-07b8-8664-e063-6394a90a7e70
{
  "name": "Carbamazepine",
  "splId": "5e7d0501-07b8-8664-e063-6394a90a7e70",
  "labels": [
    {
      "setId": "48080efd-1781-4585-83f8-c43957ac63b3",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48080efd-1781-4585-83f8-c43957ac63b3",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=48080efd-1781-4585-83f8-c43957ac63b3"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Umedica Laboratories USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-059-01)",
      "package_ndc": "60290-059-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220820"
    },
    {
      "sample": false,
      "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-059-02)",
      "package_ndc": "60290-059-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220820"
    }
  ],
  "productId": "60290-059_5e7d0501-07b8-8664-e063-6394a90a7e70",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "60290-059",
  "deaSchedule": null,
  "genericName": "Carbamazepine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CARBAMAZEPINE",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "ANDA216594",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220820",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486",
      "N0000175751",
      "N0000185506",
      "N0000191266",
      "N0000187064",
      "N0000185507",
      "N0000185607"
    ],
    "upc": [
      "0360290058014",
      "0360290058021",
      "0360290060024",
      "0360290059028"
    ],
    "unii": [
      "33CM23913M"
    ],
    "rxcui": [
      "199378",
      "402505",
      "402506"
    ],
    "spl_set_id": [
      "48080efd-1781-4585-83f8-c43957ac63b3"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
      "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 3A4 Inducers [MoA]",
      "Cytochrome P450 1A2 Inducers [MoA]",
      "Cytochrome P450 2B6 Inducers [MoA]",
      "Cytochrome P450 2C9 Inducers [MoA]",
      "Cytochrome P450 2C19 Inducers [MoA]"
    ],
    "manufacturer_name": [
      "Umedica Laboratories USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:60290-059_5e7d0501-07b8-8664-e063-6394a90a7e70"